Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Wei

Showing results (871-880 of 938) with videos related to

Pageof 94
Sort By:
Ultramicroscopy|May 8, 2019
Direct observation of magnetic contrast obtained by photoemission electron microscopy with deep ultra-violet laser excitationY C Zhao, H C Lyu, G Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2019
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid FeaturesBradley A McGregor, Rana R McKay, David A Braun, et al.
The Journal of Urology|September 16, 2020
Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial CarcinomaXiao X Wei, Lillian Werner, Min Y Teo, et al.
British Journal of Cancer|December 21, 2019
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinomaAmin H Nassar, Kent W Mouw, Opeyemi Jegede, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2026
Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)Susan Slovin, Xin Gao, Xiao X Wei, et al.
Lancet (London, England)|September 18, 2024
<sup>177</sup>Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trialMichael J Morris, Daniel Castellano, Ken Herrmann, et al.
Cell Death and Differentiation|March 28, 2024
AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell deathJia Jia, Wenbo Ji, Antoine N Saliba, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 27, 2024
Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast CancerMelanie Dawe, Wei Shi, Tian Y Liu, et al.
Nucleic Acids Research|October 16, 2025
Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistanceCordelia D McGehee, X Wei Meng, Xinyan Wu, et al.
Science Translational Medicine|August 27, 2025
Antigen-Fc fusion therapy reduces severity of a model of pemphigus vulgaris without systemic immunosuppressionSoheil Tavakolpour, Ali Nili, Leïla A Munaretto, et al.
Pageof 94

Showing results (871-880 of 938) with videos related to

Sort By:
Pageof 94
Ultramicroscopy|May 8, 2019
Direct observation of magnetic contrast obtained by photoemission electron microscopy with deep ultra-violet laser excitationY C Zhao, H C Lyu, G Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2019
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid FeaturesBradley A McGregor, Rana R McKay, David A Braun, et al.
The Journal of Urology|September 16, 2020
Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial CarcinomaXiao X Wei, Lillian Werner, Min Y Teo, et al.
British Journal of Cancer|December 21, 2019
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinomaAmin H Nassar, Kent W Mouw, Opeyemi Jegede, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2026
Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)Susan Slovin, Xin Gao, Xiao X Wei, et al.
Lancet (London, England)|September 18, 2024
<sup>177</sup>Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trialMichael J Morris, Daniel Castellano, Ken Herrmann, et al.
Cell Death and Differentiation|March 28, 2024
AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell deathJia Jia, Wenbo Ji, Antoine N Saliba, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 27, 2024
Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast CancerMelanie Dawe, Wei Shi, Tian Y Liu, et al.
Nucleic Acids Research|October 16, 2025
Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistanceCordelia D McGehee, X Wei Meng, Xinyan Wu, et al.
Science Translational Medicine|August 27, 2025
Antigen-Fc fusion therapy reduces severity of a model of pemphigus vulgaris without systemic immunosuppressionSoheil Tavakolpour, Ali Nili, Leïla A Munaretto, et al.
Pageof 94